Milestone is pleased to welcome Bhagath Chirra. Bhagath recently joined Milestone as Sr. Manager, Publications. Welcome to the team, Bhagath!

How long have you been living with #PSVT? Do you have #SVT episodes once a day or once a year? We're interested in hearing your story. Email us at [email protected] and you could be chosen to engage as a Patient Ambassador.

Dana had to learn quickly how to #OutsmartPSVT. Now, she encourages others to take control of their own health through support groups and educational sources. Watch Dana's story here: outsmartpsvt.com/heart-to-heart/

The #OutsmartPSVT toolkit is a free educational resource that includes a heart beat cheat sheet, guide for starting a conversation with your doctor and a clinical trials brochure! Unlock the toolkit at: outsmartpsvt.com/unlock-answers…

Milestone Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Corporate Update investors.milestonepharma.com/news-releases/…

Congratulations to Arrhythmia Alliance SVT Healthcare Pioneers of 2023: Prof. Uzun Cardiff and Vale University Health Board, Wales, Cardiff, UK, 1st place, 'Transforming Ambulatory Rhythm Monitoring in Children'; Megan Dale Buckinghamshire Healthcare NHS Trust, UK, 2nd place for Mobile App Clinics. Joint 2nd place: Dr. Ang, Barts Heart.

Did you know: During a #PSVT episode, heart rates can increase dramatically, sometimes exceeding 250 beats per minute. To put that in perspective, a normal heart rate is between 60-100 beats per minute. Learn more about PSVT at: milestonepharma.com/areas-of-focus…

Did you know: During a #PSVT episode, heart rates can increase dramatically, sometimes exceeding 250 beats per minute. To put that in perspective, a normal heart rate is between 60-100 beats per minute. Learn more about PSVT at: bit.ly/PSVTawareness

September marks #NationalAFibAwarenessMonth! #AtrialFibrillation occurs when the upper chambers of the heart beat irregularly and is estimated to affect 5 million patients in the United States. Join us in raising awareness about #Afib milestonepharma.com/areas-of-focus…

On September 30th, we will be participating in the American Heart Association Heart Walk. Research shows that more people in the US and CA are sitting more and moving less than prior to the pandemic. Please join us in creating a more active lifestyle. #hearthealth CharlotteHeartWalk.org

During this National Health Education Week #NHEW, check out OutsmartPSVT.com, our website that provides education to those living with #SVT. Milestone is committed to improving the lives of people living with heart conditions like SVT. outsmartpsvt.com #SVTawareness

Today we are pleased to share that we submitted a New Drug Application to the FDA for our investigational product to help patients living with #PSVT. Learn more: prnewswire.com/news-releases/…

Attending #AHA23 this weekend? Come stop by our booth (#2911/B2659) to learn how we are addressing the unmet need for patients with #AFib with RVR and #PSVT. We look forward to seeing you there!

Today, we presented positive results from our Phase 2 ReVeRA clinical study evaluating patients with #AFib with RVR at #AHA23. The results were simultaneously published in CircEP. Learn more: bitly.ws/324ss

Tomorrow is the last day at #AHA23! Join us today and tomorrow at booth (#2911/B2659) to hear more about our Phase 2 ReVeRA clinical study and how we are addressing the unmet need in #AFib with RVR and #PSVT. Read more here: bitly.ws/324ss

Today, we reported our financial results for the Third Quarter 2023. Learn more about these results and progress in our clinical development program here: bit.ly/3ukNClV

Attending #CVCT2023 in Washington D.C.? Our experts will be sharing the latest data on #AFib with RVR and #PSVT. We look forward to seeing you there. Learn more about our #clinicaltrials here: bit.ly/47Dzq6m

#ICYMI: We announced results from our Phase 2 ReVeRA clinical study evaluating patients with #AFib with RVR at #AHA23. You can hear more about the unmet need and results from Dr. James Ip who spoke with HCPLive.

Attending Western Atrial Fibrillation Symposium this weekend? Members of our leadership team, including James Nunez and Rick Sherwood, will be sharing data updates about our lead investigational product, etripamil, for AFib-RVR. We look forward to seeing you there! #WAFib2024 #AFib

We joined the #cardiovascular community Western Atrial Fibrillation Symposium this week to discuss the latest advancements in atrial fibrillation. From our clinical development program, we shared the latest Ph2 data on investigational etripamil for AFib-RVR. #WAFib2024 #AFib milestonepharma.com/research-devel…